) (11.18) Net Profit (Loss) (43.62) (6.22) 37.40 601.29 Earnings per share (Baht per share) (0.008) (0.001) 0.007 700.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of

gain (loss) from investment value of the associate and joint venture -0.53 2.26 -2.79 -123.46% The overview of revenue for 3-month period ended June 30, 2019 by comparing to the same period of the last

for period of the second quarter ended 30 June 2019, for your information and publication. In the second quarter of 2019, the Company and its subsidiaries recorded the net profit in the amount of

Total Expenses 2,436.2 70.5 1,649.8 68.5 (786.4) (32.3) Profit from operating activities 1,017.1 29.5 758.5 31.5 (258.6) (25.4) Share of gain (loss) from investments in joint ventures (44.9) (1.3) 139.1

) 46.08 82.41 (273.28%) (409.90%) 22.79 269.61 (91.55%) Basic earnings per share (Baht per share) (0.1085) 0.0350 0.0630 (272.21%) (409.83%) 0.0174 0.2061 (91.58%) Net Profit For 3rd quarter of 2022 ended

MB, an increase by 166.2 MB from as at December 31, 2021, which equals to 3,061.2 MB, an increase of 5.4% by the increase came from the profit from operations and gain on sales of investment in Genesis

profit of THB 60mn, increased by 183.0% YoY. For more details of the Company’s performance, please see 3Q 2017 performance analysis. With the upcoming Royal Cremation Ceremonies for the late King in

Profit (Annualised) / Average Total Shareholders’ equity (average of outstanding at end of the same period in the previous year and at end of this quarter) 4 Earnings before interest and tax (Annualised

%) and IPD (10%). This promising growth was due to more subspecialties, more Operation : Consolidated Profit & Loss Statement 2Q 2Q % 6 mth 6 mth % Unit : THB million 2019 2018 change 2019 2018 change

period ending June 30, 2018. The consolidated statements represent the net profit of Baht 31.41 million, which decreased by Baht 61.24 million or 66.10% comparing to the same period of 2017. While the